# Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

> **NCT05620342** · EARLY_PHASE1 · RECRUITING · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 24 (estimated)

## Conditions studied

- Lung Cancer
- Small Cell Lung Carcinoma
- Non Small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** iC9.GD2.CAR.IL-15 T Infusion

## Key facts

- **NCT ID:** NCT05620342
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-21
- **Primary completion:** 2027-11-24
- **Final completion:** 2029-10-24
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05620342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05620342, "Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05620342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*